Disposable Incontinence Products Market - By Product (Protective Incontinence Garments, Urine Bag, Urinary Catheter), By Application (Urine Incontinence, Fecal Incontinence, Dual Incontinence), By Incontinence Type (Stress, Urge, Mixed), By Disease (Femin

Disposable Incontinence Products Market - By Product (Protective Incontinence Garments, Urine Bag, Urinary Catheter), By Application (Urine Incontinence, Fecal Incontinence, Dual Incontinence), By Incontinence Type (Stress, Urge, Mixed), By Disease (Feminine Health, Chronic Disease, Bladder Cancer, Mental Disorders), By Material, By Gender, By Age, By Distribution Channel, By End-use & Global Forecast, 2023 - 2032

The disposable incontinence products market is projected to showcase a lucrative growth trajectory over 2032. Increasing geriatric population, growing R&D activities and advancements in science and technology will offer lucrative business prospects for the manufacturers of disposable incontinence products.

The penetration rate of adult diapers is 12% worldwide with Japan showcasing the highest penetration of 80%. North America and European countries follow Japan with 65% and 58% penetration rates of adult diapers respectively. Furthermore, several countries such as China have a massive elderly population with relatively lower penetration of incontinence products, indicating substantial opportunities for industry expansion.

In September 2022, Attindas Hygiene Partners launched its innovative disposable incontinence underwear in North America. The product provides up to 100% leak-free protection to users with the company’s Maxi Comfort ultrasonic bonding technology.

The disposable incontinence products market is classified into product, application, incontinence type, disease, material, gender, age, distribution channel, end-use, and region.

Based on product, the market is bifurcated into urinary catheters, protective incontinence garments, and urinary bags. The urinary catheter segment is expected to exhibit over 7% CAGR between 2023-2032. Rising prevalence of urinary tract infections (UTIs) will propel the demand for urinary catheters. According to the NCBI data, in 2019, nearly 404.6 million people worldwide had UTIs. Additionally, unhygienic health practices and an increasing geriatric population will complement the segment growth.

In terms of application, fecal incontinence held a sizeable market share in 2022. Owing to the rising geriatric population, the incidences of fecal incontinence have increased considerably in recent years. Diarrhea, bloating, constipation, and hemorrhoids are health conditions that increase the need for care pertaining to fecal incontinence. For instance, the World Federation of Incontinence & Pelvic Problems reported fecal incontinence in approximately 15% of the global population above 40 years of age.

By incontinence type, the market landscape is segregated into urge, mixed, stress, and others. The urge incontinence segment was valued at over USD 1.5 billion in 2022. The presence of a large patient pool suffering from neurological disorders, diabetes, and infections indicates a high chance of urge incontinence. It is a condition associated with poor bladder control and involuntary urination. A surging number of individuals with urinary incontinence will accelerate the segment growth.

With regards to disease, the industry is divided into mental disorders, chronic disease, feminine health, bladder cancer, benign prostatic hyperplasia, and others. Chronic diseases segment is poised to record substantial growth over 2032. Increasing prevalence of kidney disease, Parkinson’s disease, bowel & bladder infections, multiple sclerosis, and diabetes will fuel the need for incontinence care products.

For instance, Alzheimer’s disease is one of the most prevalent chronic disorders and a leading cause of incontinence. According to the Alzheimer’s Association, nearly 6 million cases of Alzheimer’s disease were reported in the U.S. in 2021.

From regional frame of reference, North America disposable incontinence products market size reached over USD 2.5 billion in 2022. Favorable reimbursement policies, rising number of patients suffering from chronic and urinary disorders, and a solid footprint of industry players will offer lucrative scope for regional market expansion.

Bladder disease is a common health condition among American adults causing UTIs. According to the Centers for Disease Control and Prevention (CDC), bladder cancer affects nearly 18,000 women, and 57,000 men in the U.S. each year. Increasing demand for optimum care associated with urological diseases will boost product adoption across North America.